Free Trial

UiPath (NYSE:PATH) Downgraded by DA Davidson to "Underperform"

UiPath logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • DA Davidson downgraded UiPath to “Underperform” from “Neutral” and set a $10 price target, implying roughly 19% downside from the cited $12.34 share price.
  • Analyst sentiment remains cautious: UiPath has a consensus “Hold” rating and an average target price of $15.69, with 15 Hold, four Buy and two Sell ratings.
  • UiPath’s latest quarterly results met EPS expectations and exceeded revenue estimates, with revenue rising 13.3% year over year; however, insiders sold about $24.7 million of stock over the past 90 days.
  • MarketBeat previews top five stocks to own in December.

UiPath (NYSE:PATH - Get Free Report) was downgraded by equities researchers at DA Davidson from a "neutral" rating to an "underperform" rating in a report issued on Monday, MarketBeat reports. They currently have a $10.00 price objective on the stock. DA Davidson's price target indicates a potential downside of 18.98% from the stock's current price.

Several other analysts have also recently issued reports on PATH. KeyCorp reaffirmed a "sector weight" rating on shares of UiPath in a research report on Thursday, September 24th. Royal Bank Of Canada reissued an "outperform" rating on shares of UiPath in a research report on Wednesday, September 23rd. Weiss Ratings upgraded UiPath from a "hold (c-)" rating to a "hold (c)" rating in a research note on Wednesday, September 9th. Mizuho lifted their target price on UiPath from $12.00 to $14.00 and gave the company a "neutral" rating in a research note on Friday, September 4th. Finally, Oppenheimer reiterated a "market perform" rating on shares of UiPath in a report on Friday, September 4th. Four analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $15.69.

Get Our Latest Stock Analysis on UiPath

UiPath Stock Performance

UiPath stock traded up $0.15 during midday trading on Monday, hitting $12.34. 36,177,211 shares of the company's stock were exchanged, compared to its average volume of 46,961,734. The company has a market cap of $6.43 billion, a PE ratio of 18.42, a P/E/G ratio of 1.17 and a beta of 1.02. The firm has a 50-day moving average of $14.53 and a two-hundred day moving average of $12.24. UiPath has a 12 month low of $9.20 and a 12 month high of $19.84.

UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings results on Thursday, September 3rd. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. UiPath had a net margin of 21.03% and a return on equity of 9.70%. The business had revenue of $410.26 million during the quarter, compared to analyst estimates of $397.77 million. During the same quarter in the previous year, the business posted $0.15 EPS. The company's quarterly revenue was up 13.3% compared to the same quarter last year. As a group, equities analysts expect that UiPath will post 0.49 earnings per share for the current year.

Insider Buying and Selling at UiPath

In other news, COO Ashim Gupta sold 117,339 shares of the business's stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $13.85, for a total transaction of $1,625,145.15. Following the sale, the chief operating officer owned 2,037,377 shares in the company, valued at approximately $28,217,671.45. The trade was a 5.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Daniel Dines sold 1,402,347 shares of the company's stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $16.07, for a total transaction of $22,535,716.29. Following the transaction, the chief executive officer owned 26,491,238 shares in the company, valued at approximately $425,714,194.66. This trade represents a 5.03% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 1,560,150 shares of company stock worth $24,727,357. 22.44% of the stock is owned by insiders.

Institutional Trading of UiPath

Several large investors have recently bought and sold shares of PATH. Trifecta Capital Advisors LLC acquired a new stake in shares of UiPath during the second quarter worth $27,000. AdvisorNet Financial Inc increased its position in shares of UiPath by 750.0% in the 1st quarter. AdvisorNet Financial Inc now owns 3,400 shares of the company's stock valued at $38,000 after acquiring an additional 3,000 shares during the period. REAP Financial Group LLC acquired a new position in shares of UiPath in the 4th quarter valued at $44,000. Global Retirement Partners LLC purchased a new position in UiPath in the 2nd quarter worth $57,000. Finally, EverSource Wealth Advisors LLC raised its stake in UiPath by 36.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 4,968 shares of the company's stock worth $81,000 after acquiring an additional 1,329 shares during the last quarter. Hedge funds and other institutional investors own 62.50% of the company's stock.

Key Headlines Impacting UiPath

Here are the key news stories impacting UiPath this week:

About UiPath

(Get Free Report)

UiPath Inc NYSE: PATH develops enterprise automation software designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation (RPA), artificial intelligence, workflow orchestration and process intelligence to support automation across areas such as finance, customer service, human resources, information technology and operations.

The UiPath Platform includes tools for discovering and analyzing business processes, building and managing software robots, processing documents, testing applications and coordinating automated workflows.

Further Reading

Analyst Recommendations for UiPath (NYSE:PATH)

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines